Joseph P. Lucia & Associates, LLC Abb Vie Inc. Transaction History

Joseph P. Lucia & Associates, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $27,583 - $34,223	209 New	209 $34,000
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $62,524 - $79,111	-582 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $5,320 - $6,039	50 Added 9.4%	582 $63,000
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $29,248 - $32,584	278 Added 109.45%	532 $60,000
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $1,534 - $1,689	-15 Reduced 5.58%	254 $27,000
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $21,651 - $29,232	269 New	269 $29,000
Q3 2020 Oct 20, 2020	SELL	$85.91 - $100.83 $35,137 - $41,239	-409 Closed	0 $0
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $721 - $902	-10 Reduced 2.39%	409 $36,000
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $3,778 - $4,543	-60 Reduced 12.53%	419 $32,000
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $1.62 Million - $2.07 Million	-24,628 Reduced 98.09%	479 $35,000
Q1 2019 May 02, 2019	BUY	$77.14 - $90.79 $1.94 Million - $2.28 Million	25,107 New	25,107 $299,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.